Form 4: Arteris Director Antonio J. Viana Reports Acquisition of Restricted Stock Units
Insider Transaction Report
Arteris, Inc. Director Antonio J. Viana reported the acquisition of 20,839 restricted stock units (RSUs) on June 3, 2025, as part of his compensation.
Summary
- Antonio J. Viana, a Director of Arteris, Inc. (AIP), acquired 20,839 shares of common stock on June 3, 2025.
- These shares were granted as Restricted Stock Units (RSUs) at a price of $0.00 per unit.
- The RSUs are scheduled to vest in full on the earlier of the first anniversary of the grant date or immediately before the annual meeting of the Issuer's stockholders following the grant date, contingent upon Mr. Viana's continued service to the Board.
- Following this transaction, Mr. Viana directly beneficially owns 41,679 shares of common stock and indirectly owns 201,330 shares through the Viana Family Trust, resulting in a total beneficial ownership of 243,009 shares.
Sentiment
Score: 7
Explanation: The filing reports a routine equity grant to a director, which is generally a positive sign of alignment between the board and shareholders, but it does not contain significant new operational or financial news to warrant a higher score.
Positives
- The grant of Restricted Stock Units (RSUs) to Director Antonio J. Viana aligns his interests with long-term shareholder value, as vesting is tied to his continued service and the company's stock performance.
- An increase in direct beneficial ownership by a director can signal confidence in the company's future prospects and strategic direction.
Negatives
- No explicit negatives are present in this Form 4 filing, as it primarily reports a routine equity grant.
Risks
- The ultimate value of the granted RSUs is contingent upon the future market performance of Arteris, Inc.'s common stock.
- Vesting of the RSUs is subject to the reporting person continuing to provide services to the Issuer's Board through the specified vesting date.
Future Outlook
The Restricted Stock Units are designed to vest over approximately one year, aligning the director's future compensation with the company's performance and his continued service to the Board.
Industry Context
This Form 4 filing reports a standard equity compensation practice for directors in publicly traded technology companies, which aims to align their long-term interests with those of shareholders.
Comparison to Industry Standards
- The grant of Restricted Stock Units (RSUs) as part of director compensation is a common practice across the technology sector and aligns with typical corporate governance standards for incentivizing long-term commitment.
- The vesting schedule, tied to continued service, is standard for such equity awards, similar to practices observed at comparable companies in the semiconductor IP or electronic design automation (EDA) industries.
Stakeholder Impact
- Shareholders: The grant of RSUs to a director aligns their interests with shareholders, as the value of the compensation is directly tied to the company's stock performance over time.
Next Steps
- The RSUs are expected to vest on the earlier of June 3, 2026 (the first anniversary of the grant date) or immediately before Arteris, Inc.'s annual meeting of stockholders following the grant date, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 06/03/2025 | Date of the RSU grant transaction. |
| 06/05/2025 | Date the Form 4 was signed by the attorney-in-fact for Antonio J. Viana. |
Recommendation
holdKeywords
Arteris Inc., AIP, Form 4, SEC filing, insider transaction, restricted stock units, RSUs, beneficial ownership, director compensation, equity grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.